• FCMS
  • Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust
  • Rotherham Doncaster and South Humber NHS Foundation Trust
  • Nottingham and Nottinghamshire
  • South Yorkshire ICB

Hide Non-Formulary Medicines and Products

Chronic hepatitis B

Rationale: 1, 6

Pack Price
30 tablet

Treatment of chronic hepatitis delta virus (HDV) infection in plasma (or serum) HDV-RNA positive adults with compensated liver disease

Rationale 1,6

NICE TA896 Bulevirtide for treating chronic hepatitis D

Chronic hepatitis B infection in adults with decompensated liver disease

Rationale: 1,6

NICE Guidance 

 

Review Date: 01/07/2023

Chronic Hepatitis B infection with either compensated or decompensated liver disease

Rationale: 1,2

NICE CG165
Issued: June 2013

Review Date: 01/10/2026

Chronic Hepatitis B&C / Chronic Hepatitis C

Brand:Pegasys, ViraferonPeg, PegIntron

Rationale:1,2,3,8

NICE TA 331 has been withdrawn

 

Review Date: 01/10/2027

Hepatitis B chronic

Brand: Sebivo

Rationale: 1,2,8

NICE PH43 Hepatitis B and C testing: people at risk of infection

This guidance does not apply to people with chronic hepatitis B who also have hepatitis C, hepatitis D or HIV.

Telbivudine is not recommended for the treatment of chronic hepatitis B.
People currently receiving telbivudine should have the option to continue therapy until they and their clinicians consider it appropriate to stop.

NICE TA154 Telbivudine for the treatment of chronic hepatitis B